Company: ATLCL
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001437749-25-033947
Chunk: 52

Company: Atlanticus Holdings Corp
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 8
Chunk 52
---
 September 30, 2025, 39,215 shares remained available for issuance under the ESPP and 1,915,098 shares remained available for issuance under the Fourth Amended 2014 Plan.
    
   Exercises and vesting under our stock-based compensation plans resulted in no income tax-related charges to paid-in capital during the three and nine months ended  September 30, 2025 and 2024.
    
   Restricted Stock and Restricted Stock Units
    
   During the three months ended  September 30, 2025 and 2024, we had forfeitures (net of grants) of 8,632 shares and 583 shares of restricted stock and restricted stock units, respectively, with aggregate grant date fair values $0.3 million and $0, respectively. For the nine months ended  September 30, 2025 and 2024, we had grants (net of forfeitures) of 65,782 shares and 209,053 shares of restricted stock and restricted stock units, respectively, with aggregate grant date fair values of $3.6 million and $6.5 million, respectively. We incurred expenses of $0.9 million, $2.7 million, $1.0 million and $2.8 million during the three and nine months ended  September 30, 2025 and 2024, respectively, related to restricted stock awards. When we grant restricted stock and restricted stock units, we defer the grant date value of the restricted stock and restricted stock unit and amortize that value (net of the value of anticipated forfeitures) as compensation expense with an offsetting entry to the paid-in capital component of our condensed consolidated shareholders’ equity. Our restricted stock awards typically vest over a range of 12 to 60 months (or other term as specified in the grant which  may include the achievement of performance measures) and are amortized to salaries and benefits expense ratably over applicable vesting periods. As of  September 30, 2025, our unamortized deferred compensation costs associated with non-vested restricted stock awards were $7.3 million with a weighted-average remaining amortization period of 3.1 years. No forfeitures have been included in our compensation cost estimates based on historical forfeiture rates.
    
   The table below includes additional information about outstanding restricted stock and restricted stock units:

       Number of Shares    Weighted Average Grant Date Fair Value  
 Outstanding